Cancer is perhaps the most dreaded diseases in the world today and continues to claim millions of lives. Treatment solutions for this world’s deadly ailment have remained elusive with researchers turning to certain compounds that promise to manage the condition. One such compound is Exemestane, a Selective Androgen Receptor Modulator (SARM) that has proved incredible in treating breast cancer in women, especially after attaining menopause. It also prevents the re-occurrence of cancer of the breast by inhibiting or suppressing the production of estrogen. However, it is not supposed to be used by women in already breastfeeding or pregnant.
How to Use Exemestane
The medication is supposed to be taken orally (by mouth) and after taking a meal. The amount of the dose depends on the doctor’s prescription or your existing medical condition. It is because it is easily absorbed through the lungs as well as the skin surface, making it dangerous for breastfeeding women.
Possible Side Effects
Some of the possible side effects include sweating, dizziness, diarrhea, nausea, and sleeping problems. You need to discuss with your doctor if you have had any life-threatening conditions such as fractures or depression. So far, there are no severe side effects associated with this compound.
Conclusion
This prohormone has so far been successful as a treatment solution to breast cancer where no surgery is needed. However, the effectiveness of the compound will depend on the extent of the condition. Your doctor should advise you on what alternatives to use or when to stop using this drug.
Aromasin — A Modern Discovery For Treating Breast Cancer
Breast cancer is becomingly increasingly common among women. Studies have shown that the amount of estrogen in the body influences the frequency or vulnerability of an individual to breast cancer. An enzyme known as aromatase converts androgenic compounds and testosterone into estrogen. By blocking aromatase, Aromasin ensures the limited production of estrogen in the body. Cancer is arguably one of the most dreaded diseases in the world and kills millions of unsuspecting women. Fortunately, drug developers and researchers have discovered that Aromasin (or exemestane) can help to treat cancer of the breast among postmenopausal women.
Both Arimidex (anastrozole) and exemestane are aromatase inhibitors that have been used in treating cancer in older women (or postmenopausal women). Although they present similar effects, the two drugs differ significantly in how they work.
Aromasin is the proprietary brand for exemestane. It has been confirmed by the U.S Food and Drugs Administration (FDA) as a potent treatment for estrogen-receptor-positive breast cancer in elderly females, especially two years after running a tamoxifen therapy.
Aromasin is available in 25 mg oral tablets that are taken orally once a day after eating a meal.
Aromasin Dosage and Administration
The recommended dose of Aromasin during the early breast cancer is one 25 mg tablet to be taken once daily after a meal. The dose is used in the following conditions:
• Advanced cancer in postmenopausal women whose cancer condition has progressed following the administration of tamoxifen therapy.• In adjuvant treatment of postmenopausal women who have been consistently running tamoxifen treatment to help complete the five-year treatment plan of hormonal therapy.
Adjuvant Treatment of Postmenopausal Ladies
Aromasin has been earmarked for adjuvant treatment of cancer in women who have passed menopause exhibiting estrogen-receptor positive early cancer of the breast and who have been on tamoxifen treatment for up to three years. As a hormonal therapy, Aromasin has been found to carry minimal side effects compared to its competitor drugs such as tamoxifen.
Warnings and Precautions when Using Aromasin
Studies have shown that treatment using exemestane comes with a reduction in bone mineral density, especially if the prescription is given over a long time. That is less seen when treating patients with tamoxifen or Aromasin. Therefore, patients under exemestane treatment are encouraged to supplement their diet with vitamin D, calcium, and phosphates.
During adjuvant treatment using exemestane, postmenopausal women with osteoporosis or at risk of this condition are encouraged to seek an assessment of the bone mineral density upon starting the treatment. That will help minimize the chances of wasting and injuries.
Vitamin D Assessment
It is also recommended to go for a routine assessment of 25-hydroxy vitamin D levels before starting the treatment. That is because of the high vitamin D deficiency among postmenopausal women with breast cancer. If you are vitamin D deficient, it is advisable to incorporate vitamin D supplement foods in your diet.
Final Thought
Do not let breast cancer eat you up, yet there’s a way of dealing with it. Based on the reviews from online users, Aromasin appears to be a better alternative to Arimidex since it can reduce estrogen production by 85% compared to 80% that Arimidex offers. Also, it is superior in the production of IGF-1, which is a necessary hormone for the production of hormones for weightlifting and bodybuilding. However, these two drugs may work differently for different people. The answer as to which medicine is better is a subjective one. It all depends on the steroids you are using and your body mechanism. Whichever steroids you use to accompany this drug, remember to go for a Posy Cycle Therapy (PCT). Besides, be sure to buy only genuine Aromasin from a reputable store to avoid wasting your money on useless and dangerous drugs that claim to deliver the best results.